Alcohol Use and Cardiovascular Disease Risk in Patients With Nonalcoholic Fatty Liver Disease

Gastroenterology

Volumn 153, Issue 5, 2017, Pages 1260-1272.e3

  VanWagner, Lisa B ^a   Ning, Hongyan ^a   Allen, Norrina B ^a   Ajmera, Veeral ^b   Lewis, Cora E ^d   Carr, John Jeffrey ^c   Lloyd Jones, Donald M ^a,b   Terrault, Norah A ^b   Siddique, Juned ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c VANDERBILT UNIVERSITY   (United States)

^d University of Alabama at Birmingham   (United States)

Author keywords

CARDIA Study; Heart Disease; NAFLD; NASH

Indexed keywords

ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; C REACTIVE PROTEIN;

ABDOMINAL RADIOGRAPHY; ADULT; ADVERSE OUTCOME; ALCOHOL CONSUMPTION; ANTIHYPERTENSIVE THERAPY; ARTICLE; ATHEROSCLEROSIS; BLACK PERSON; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CAUCASIAN; CEREBROVASCULAR ACCIDENT; COHORT ANALYSIS; COMORBIDITY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CORONARY ARTERY CALCIFICATION; DIABETES MELLITUS; DISEASE ASSOCIATION; DRINKING BEHAVIOR; DYSLIPIDEMIA; EARLY TRANSMITRAL VELOCITY LATE TRANSMITRAL VELOCITY RATIO; EDUCATIONAL STATUS; FEMALE; FOLLOW UP; HEART HEMODYNAMICS; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART LEFT VENTRICLE ENDSYSTOLIC VOLUME; HEART LEFT VENTRICLE FILLING PRESSURE; HEART LEFT VENTRICLE MASS; HEART OUTPUT; HEART VENTRICLE HYPERTROPHY; HEART VOLUME; HEMODYNAMIC PARAMETERS; HIGH RISK PATIENT; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; IMPAIRED GLUCOSE TOLERANCE; LEFT ATRIAL VOLUME INDEX; LEFT VENTRICULAR DIASTOLIC DYSFUNCTION; LEFT VENTRICULAR SYSTOLIC DYSFUNCTION; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MIDDLE AGED; NONALCOHOLIC FATTY LIVER; OBESITY; PERIPHERAL VASCULAR DISEASE; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; SLEEP DISORDERED BREATHING; SPECKLE TRACKING ECHOCARDIOGRAPHY; THORAX RADIOGRAPHY; TISSUE DOPPLER IMAGING; YOUNG ADULT; ADOLESCENT; AGE; BINGE DRINKING; CHI SQUARE DISTRIBUTION; CLINICAL TRIAL; CORONARY ARTERY DISEASE; CROSS-SECTIONAL STUDY; DIAGNOSTIC IMAGING; DOPPLER ECHOCARDIOGRAPHY; MULTICENTER STUDY; MULTIDETECTOR COMPUTED TOMOGRAPHY; MULTIVARIATE ANALYSIS; ODDS RATIO; PATHOPHYSIOLOGY; PROGNOSIS; PROTECTION; RISK ASSESSMENT; RISK FACTOR; STATISTICAL MODEL; TIME FACTOR; UNDERAGE DRINKING; UNITED STATES;

ADOLESCENT; ADULT; AGE FACTORS; ALCOHOL DRINKING; BINGE DRINKING; CHI-SQUARE DISTRIBUTION; CORONARY ARTERY DISEASE; CROSS-SECTIONAL STUDIES; ECHOCARDIOGRAPHY, DOPPLER; FEMALE; HUMANS; LINEAR MODELS; LOGISTIC MODELS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; MULTIDETECTOR COMPUTED TOMOGRAPHY; MULTIVARIATE ANALYSIS; NON-ALCOHOLIC FATTY LIVER DISEASE; ODDS RATIO; PROGNOSIS; PROTECTIVE FACTORS; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; UNDERAGE DRINKING; UNITED STATES; YOUNG ADULT;

EID: 85032724241     PISSN: 00165085     EISSN: 15280012     Source Type: Journal    
DOI: 10.1053/j.gastro.2017.08.012     Document Type: Article

References (60)

1. Chalasani, N., Younossi, Z., Lavine, J.E., et al. The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association. Hepatology 55 (2012), 2005–2023.
2. Targher, G., Day, C.P., Bonora, E., Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease. N Engl J Med 363 (2010), 1341–1350.
3. Sanyal, A.J., Brunt, E.M., Kleiner, D.E., et al. Endpoints and clinical trial design for nonalcoholic steatohepatitis. Hepatology 54 (2011), 344–353.
4. (SAMHSA) SAaMHSA. 2015 National Survey on Drug Use and Health (NSDUH). Table 2.41B—Alcohol Use in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Demographic Characteristics: Percentages, 2014 and 2015. Volume 2017, 2015.
5. Zivkovic, A.M., German, J.B., Sanyal, A.J., Comparative review of diets for the metabolic syndrome: implications for nonalcoholic fatty liver disease. Am J Clin Nutr 86 (2007), 285–300.
6. Di Castelnuovo, A., Costanzo, S., Bagnardi, V., et al. Alcohol dosing and total mortality in men and women: an updated meta-analysis of 34 prospective studies. Arch Intern Med 166 (2006), 2437–2445.
7. Friedman, G.D., Cutter, G.R., Donahue, R.P., et al. CARDIA: study design, recruitment, and some characteristics of the examined subjects. J Clin Epidemiol 41 (1988), 1105–1116.
8. Halanych, J.H., Safford, M.M., Kertesz, S.G., et al. Alcohol consumption in young adults and incident hypertension: 20-year follow-up from the Coronary Artery Risk Development in Young Adults Study. Am J Epidemiol 171 (2010), 532–539.
9. Alcoholism. NIoAAa. Helping patients who drink too much: a clinician's guide, 2007, National Institutes of Health, Rockville, MD.
10. Costanzo, P.R., Malone, P.S., Belsky, D., et al. Longitudinal differences in alcohol use in early adulthood. J Stud Alcohol Drugs 68 (2007), 727–737.
11. Warnick, G.R., Enzymatic methods for quantification of lipoprotein lipids. Methods Enzymol 129 (1986), 101–123.
12. Friedewald, W.T., Levy, R.I., Fredrickson, D.S., Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18 (1972), 499–502.
13. Grundy, S.M., Brewer, H.B. Jr., Cleeman, J.I., et al. Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Arterioscler Thromb Vasc Biol 24 (2004), e13–e18.
14. VanWagner, L.B., Ning, H., Lewis, C.E., et al. Associations between nonalcoholic fatty liver disease and subclinical atherosclerosis in middle-aged adults: the Coronary Artery Risk Development in Young Adults study. Atherosclerosis 235 (2014), 599–605.
15. Kodama, Y., Ng, C.S., Wu, T.T., et al. Comparison of CT methods for determining the fat content of the liver. AJR Am J Roentgenol 188 (2007), 1307–1312.
16. VanWagner, L.B., Wilcox, J.E., Colangelo, L.A., et al. Association of nonalcoholic fatty liver disease with subclinical myocardial remodeling and dysfunction: a population-based study. Hepatology 62 (2015), 773–783.
17. Agatston, A.S., Janowitz, W.R., Hildner, F.J., et al. Quantification of coronary artery calcium using ultrafast computed tomography. J Am Coll Cardiol 15 (1990), 827–832.
18. Carr, J.J., Crouse, J.R. 3rd, Goff, D.C. Jr., et al. Evaluation of subsecond gated helical CT for quantification of coronary artery calcium and comparison with electron beam CT. AJR Am J Roentgenol 174 (2000), 915–921.
19. Detrano, R.C., Anderson, M., Nelson, J., et al. Coronary calcium measurements: effect of CT scanner type and calcium measure on rescan reproducibility–MESA study. Radiology 236 (2005), 477–484.
20. Chung, H., McClelland, R.L., Katz, R., et al. Repeatability limits for measurement of coronary artery calcified plaque with cardiac CT in the multi-ethnic study of atherosclerosis. AJR Am J Roentgenol 190 (2008), W87–W92.
21. Budoff, M.J., McClelland, R.L., Chung, H., et al. Reproducibility of coronary artery calcified plaque with cardiac 64-MDCT: the Multi-Ethnic Study of Atherosclerosis. AJR Am J Roentgenol 192 (2009), 613–617.
22. Gidding, S.S., Liu, K., Colangelo, L.A., et al. Longitudinal determinants of left ventricular mass and geometry: the Coronary Artery Risk Development in Young Adults (CARDIA) study. Circ Cardiovasc Imaging 6 (2013), 769–775.
23. Kishi, S., Armstrong, A., Gidding, S.S., et al. Association of obesity in early adulthood and middle age with incipient left ventricular dysfunction and structural remodeling: the Coronary Artery Risk Development in Young Adults (CARDIA) study. JACC Heart Fail 2 (2014), 500–508.
24. Nagueh, S.F., Appleton, C.P., Gillebert, T.C., et al. Recommendations for the evaluation of left ventricular diastolic function by echocardiography. J Am Soc Echocardiogr 22 (2009), 107–133.
25. Mukamal, K.J., Chung, H., Jenny, N.S., et al. Alcohol consumption and risk of coronary heart disease in older adults: the Cardiovascular Health Study. J Am Geriatr Soc 54 (2006), 30–37.
26. Rimm, E.B., Williams, P., Fosher, K., et al. Moderate alcohol intake and lower risk of coronary heart disease: meta-analysis of effects on lipids and haemostatic factors. BMJ 319 (1999), 1523–1528.
27. Li, J.M., Mukamal, K.J., An update on alcohol and atherosclerosis. Curr Opin Lipidol 15 (2004), 673–680.
28. Koppes, L.L., Dekker, J.M., Hendriks, H.F., et al. Moderate alcohol consumption lowers the risk of type 2 diabetes: a meta-analysis of prospective observational studies. Diabetes Care 28 (2005), 719–725.
29. Mukamal, K.J., Ding, E.L., Djousse, L., Alcohol consumption, physical activity, and chronic disease risk factors: a population-based cross-sectional survey. BMC Publ Health, 6, 2006, 118.
30. Fillmore, K.M., Golding, J.M., Graves, K.L., et al. Alcohol consumption and mortality. I. Characteristics of drinking groups. Addiction 93 (1998), 183–203.
31. Gunji, T., Matsuhashi, N., Sato, H., et al. Alcohol consumption is inversely correlated with insulin resistance, independent of metabolic syndrome factors and fatty liver diseases. J Clin Gastroenterol 45 (2011), 808–813.
32. Davies, M.J., Baer, D.J., Judd, J.T., et al. Effects of moderate alcohol intake on fasting insulin and glucose concentrations and insulin sensitivity in postmenopausal women: a randomized controlled trial. JAMA 287 (2002), 2559–2562.
33. Yeboah, J., McClelland, R.L., Polonsky, T.S., et al. Comparison of novel risk markers for improvement in cardiovascular risk assessment in intermediate-risk individuals. JAMA 308 (2012), 788–795.
34. Yang, T., Doherty, T.M., Wong, N.D., et al. Alcohol consumption, coronary calcium, and coronary heart disease events. Am J Cardiol 84 (1999), 802–806.
35. Tofferi, J.K., Taylor, A.J., Feuerstein, I.M., et al. Alcohol intake is not associated with subclinical coronary atherosclerosis. Am Heart J 148 (2004), 803–809.
36. McClelland, R.L., Bild, D.E., Burke, G.L., et al. Alcohol and coronary artery calcium prevalence, incidence and progression: results from the Multi-Ethnic Study of Atherosclerosis (MESA). Am J Clin Nutr 88 (2008), 1593–1601.
37. Vliegenthart, R., Oei, H.H., van den Elzen, A.P., et al. Alcohol consumption and coronary calcification in a general population. Arch Intern Med 164 (2004), 2355–2360.
38. Pletcher, M.J., Varosy, P., Kiefe, C.I., et al. Alcohol consumption, binge drinking, and early coronary calcification: findings from the Coronary Artery Risk Development in Young Adults (CARDIA) Study. Am J Epidemiol 161 (2005), 423–433.
39. Mathews, E.C. Jr., Gardin, J.M., Henry, W.L., et al. Echocardiographic abnormalities in chronic alcoholics with and without overt congestive heart failure. Am J Cardiol, 47, 1981 570-58.
40. Goncalves, A., Claggett, B., Jhund, P.S., et al. Alcohol consumption and risk of heart failure: the Atherosclerosis Risk in Communities Study. Eur Heart J 36 (2015), 939–945.
41. Walsh, C.R., Larson, M.G., Evans, J.C., et al. Alcohol consumption and risk for congestive heart failure in the Framingham Heart Study. Ann Intern Med 136 (2002), 181–191.
42. Bryson, C.L., Mukamal, K.J., Mittleman, M.A., et al. The association of alcohol consumption and incident heart failure: the Cardiovascular Health Study. J Am Coll Cardiol 48 (2006), 305–311.
43. Centers for Disease Control and Prevention. Alcohol and Public Health Frequently Asked Questions. Available at: https://www.cdc.gov/alcohol/faqs.htm.
44. Sinn, D.H., Gwak, G.Y., Cho, J., et al. Modest alcohol consumption and carotid plaques or carotid artery stenosis in men with non-alcoholic fatty liver disease. Atherosclerosis 234 (2014), 270–275.
45. Hajifathalian, K., McCullough, A., Effect of alcohol consumption on survival in nonalcoholic fatty liver disease: a national prospective cohort study. 2017, Digestive Diseases Week, Chicago, IL.
46. Ajmera, V.H., Terrault, N.A., Harrison, S.A., Is moderate alcohol use in non-alcoholic fatty liver disease good or bad? a critical review. Hepatology 65 (2017), 2090–2099.
47. Dunn, W., Sanyal, A.J., Brunt, E.M., et al. Modest alcohol consumption is associated with decreased prevalence of steatohepatitis in patients with non-alcoholic fatty liver disease (NAFLD). J Hepatol 57 (2012), 384–391.
48. Kwon, H.K., Greenson, J.K., Conjeevaram, H.S., Effect of lifetime alcohol consumption on the histological severity of non-alcoholic fatty liver disease. Liver Int 34 (2014), 129–135.
49. Dixon, J.B., Bhathal, P.S., O'Brien, P.E., Nonalcoholic fatty liver disease: predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese. Gastroenterology 121 (2001), 91–100.
50. Cotrim, H.P., Freitas, L.A., Alves, E., et al. Effects of light-to-moderate alcohol consumption on steatosis and steatohepatitis in severely obese patients. Eur J Gastroenterol Hepatol 21 (2009), 969–972.
51. Dunn, W., Xu, R., Schwimmer, J.B., Modest wine drinking and decreased prevalence of suspected nonalcoholic fatty liver disease. Hepatology 47 (2008), 1947–1954.
52. Sookoian, S., Castano, G.O., Pirola, C.J., Modest alcohol consumption decreases the risk of non-alcoholic fatty liver disease: a meta-analysis of 43 175 individuals. Gut 63 (2014), 530–532.
53. Ajmera, V., Belt, P., Wilson, L., et al. No benefit from modest alcohol use in nonalcoholic fatty liver disease. The Liver Meeting. 2016, American Association for the Study of Liver Diseases, Boston, MA.
54. Sookoian, S., Flichman, D., Castano, G.O., et al. Mendelian randomisation suggests no beneficial effect of moderate alcohol consumption on the severity of nonalcoholic fatty liver disease. Aliment Pharmacol Ther 44 (2016), 1224–1234.
55. Ekstedt, M., Franzen, L.E., Holmqvist, M., et al. Alcohol consumption is associated with progression of hepatic fibrosis in non-alcoholic fatty liver disease. Scand J Gastroenterol 44 (2009), 366–374.
56. Musso, G., Gambino, R., Cassader, M., et al. Meta-analysis: natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity. Ann Med 43 (2011), 617–649.
57. Blais, P., Husain, N., Kramer, J.R., et al. Nonalcoholic fatty liver disease is underrecognized in the primary care setting. Am J Gastroenterol 110 (2015), 10–14.
58. Rimm, E.B., Klatsky, A., Grobbee, D., et al. Review of moderate alcohol consumption and reduced risk of coronary heart disease: is the effect due to beer, wine, or spirits. BMJ 312 (1996), 731–736.
59. Costanzo, S., Di Castelnuovo, A., Donati, M.B., et al. Wine, beer or spirit drinking in relation to fatal and non-fatal cardiovascular events: a meta-analysis. Eur J Epidemiol 26 (2011), 833–850.
60. Di Castelnuovo, A., Rotondo, S., Iacoviello, L., et al. Meta-analysis of wine and beer consumption in relation to vascular risk. Circulation 105 (2002), 2836–2844.